Home | My NASDAQ | Tools | Mobile | Company List | ETFs | Pre-Market Quotes Real-Time Quotes After Hours Quotes
Home > Quotes > HGSI > Company News
HGSI
HGSI
$13.61
*
0.01
negative
0.07%

*Data as of May 25, 2012   | Human Genome Sciences, Inc. | Industry: Health Care | HQ: Maryland, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 |  Sponsored

HGSI News Headlines

Share |


   


Analysts' Actions: ARO, DUK, PPG
5/24/2012 8:58:00 AM - TheStreet

U.S. Stock Futures Higher Despite Weak Economic Data in China and Europe
5/24/2012 8:14:00 AM - Knobias

European Shares Seen Slightly Higher
5/24/2012 2:04:00 AM - RTT News

GlaxoSmithKline Amends Offer In Response To Human Genome Poison Pill
5/23/2012 1:29:00 PM - RTT News

Glaxo Amends Offer To Address HGS Shareholder Rights Plan
5/23/2012 8:57:00 AM - Dow Jones Business News

GSK Amends Tender Offer Conditions To Address HGS' Adoption Of Poison Pill
5/23/2012 8:44:00 AM - RTT News

Will Anthera's PEARL Shine Or Sink?
5/19/2012 5:37:00 AM - RTT News

Glaxo Fails to Impress HGSI - Analyst Blog
5/18/2012 5:40:22 PM - Zacks.com

European Shares Set To Fall On EU&US Worries
5/18/2012 2:25:00 AM - RTT News

ADR Report: Shares Lower As Euro-Zone Worries Loom
5/17/2012 5:30:00 PM - Dow Jones Business News

U.S Markets Sell Off on European Fears
5/17/2012 4:27:00 PM - Knobias

GlaxoSmithKline To Proceed With Tender Offer To Acquire Human Genome - Update
5/17/2012 3:26:00 PM - RTT News

GSK Says It Continues To Proceed With Human Genome Sciences Tender Offer
5/17/2012 1:56:00 PM - RTT News

UPDATE: Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo
5/17/2012 1:44:00 PM - Dow Jones Business News

Glaxo Hikes Stake in Theravance - Analyst Blog
5/17/2012 1:39:50 PM - Zacks.com

GlaxoSmithKline Offer To Acquire HGS Represents Full, Fair Value
5/17/2012 1:38:00 PM - Dow Jones Business News

Stocks Weaken Further at Midday
5/17/2012 1:29:00 PM - Knobias

Human Genome Looks to Anyone but GlaxoSmithKline
5/17/2012 10:43:14 AM - Benzinga

Stocks Lower in Early Trading on Weak Economic Data and European Concerns
5/17/2012 10:40:00 AM - Knobias

Bankia Customers Withdraw 1B Euros in One Week: Hot Trends
5/17/2012 9:33:00 AM - TheStreet

Futures Mixed-to-Flat as Weekly Jobless Claims Remain Unchanged at 370K
5/17/2012 9:14:00 AM - Knobias

Futures Lower in Premarket on European Concerns
5/17/2012 8:19:00 AM - Knobias

Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo
5/17/2012 7:40:00 AM - Dow Jones Business News

Human Genome Sciences Urges Stockholders Reject GlaxoSmithKline's Tender Offer
5/17/2012 7:25:00 AM - RTT News

Glaxo Set to Acquire Cellzome - Analyst Blog
5/16/2012 1:08:13 PM - Zacks.com